Clinical Trial Update: A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating how well CagriSema supports long-term weight loss and maintenance in people with obesity; the study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING